@MichaelZero10@michael thereby grow in market shares at the same time(?). I would like to better be able to assess the competitiveness of OrganOx (that’s my main intention of this reply).
@MichaelZero10 Thx @Michael. I guess your conclusion is based on that OrganOx has been live in the market since the FDA approval. Do we know how likely this is? Also, in theory both OrganOx and Transmedics could take shares from legacy solutions simultaneously,
@kshriramsharma Would you be able to elaborate a bit on this, please? I’m not an AI engineer so I look at the numbers they present. What do you see, with your perspective? 🙏